POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Missouri prohibits health plans from denying or charging higher cost-sharing for nonopioid acute pain medications

Original title: INSURANCE COVERAGE OF ALTERNATIVES TO OPIOID DRUGS

Last action · January 29, 2026: HCS Reported Do Pass (H)Sponsors: Brian Seitz and 1 other

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

s in Missouri are prohibited from denying coverage for nonopioid prescription drugs prescribed for in favor of opioids, requiring patients to try opioids first, or charging higher cost-sharing for nonopioids starting January 1, 2027.

Why it matters

Patients prescribed nonopioid alternatives for are ensured equal coverage terms and pricing compared to opioid medications under covered s.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

enrollees

Enrollees gain guaranteed access to nonopioid prescription drugs for acute pain without being subjected to mandatory opioid trial periods or higher cost-sharing.

Directly affected

health care professional

Health care professionals prescribing nonopioid medications for acute pain are assured that health plans cannot override or penalize their prescribing decisions in favor of opioids.

Key Facts

  • Prohibits health benefit plans from denying coverage of nonopioid prescription drugs for acute pain in favor of opioid prescription drugs.
  • Bans health benefit plans from requiring enrollees to try an opioid prescription drug before covering a nonopioid prescription drug.
  • Prohibits requiring a higher level of cost-sharing for nonopioid prescription drugs than for opioid prescription drugs.
  • Defines 'acute pain' as pain expected to last thirty days or fewer resulting from disease, trauma, or other causes.
Show all 5 facts
  • Applies to health benefit plans delivered, issued for delivery, continued, or renewed on or after January 1, 2027.

Frequently Asked Questions

What does the bill require health benefit plans to do regarding nonopioid drugs?
s cannot deny coverage for a nonopioid prescription drug in favor of an opioid, require patients to try an opioid first, or charge higher cost-sharing for the nonopioid drug.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

8 actions
  1. Jan 29, 2026HouseCommittee
    HCS Reported Do Pass (H)
  2. Jan 29, 2026HouseCommittee
    HCS Voted Do Pass (H)
  3. Jan 29, 2026House
    Executive Session Completed (H)
  4. Jan 22, 2026House
    Public Hearing Completed (H)
  5. Jan 8, 2026HouseCommittee
    Referred: Health and Mental Health(H)
  6. Jan 8, 2026HouseFloor
    Read Second Time (H)
Show 2 earlier actions
  1. Jan 7, 2026HouseIntroduced
    Read First Time (H)
  2. Dec 1, 2025HouseIntroduced
    Prefiled (H)

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

General Assembly
OrganizationGeneral Assembly“Enacting body of the state of Missouri”Map →

Sources

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record